Literature DB >> 21376919

Alcohol, psychoactive drugs and fatal road traffic accidents in Norway: a case-control study.

Hallvard Gjerde1, Per T Normann, Asbjørg S Christophersen, Sven Ove Samuelsen, Jørg Mørland.   

Abstract

A case-control study was conducted on 204 drivers fatally injured in road traffic accidents in south-eastern Norway during the period 2003-2008. Cases from single vehicle accidents (N = 68) were assessed separately. As controls, 10540 drivers selected in a roadside survey in the same geographical area during 2005-2006 were used. Blood samples were collected from the cases and oral fluid (saliva) samples from the controls. Samples were analysed for alcohol, amphetamines, cannabis, cocaine, opioid analgesics, hypnotics, sedatives and a muscle relaxant; altogether 22 psychoactive substances. Equivalent cutoff concentrations for blood and oral fluid were used. The risk for fatal injury in a road traffic accident was estimated using logistic regression adjusting for gender, age, season of the year, and time of the week. The odds for involvement in fatal road traffic accidents for different substances or combination of substances were in increasing order: single drug < multiple drugs < alcohol only < alcohol+drugs. For single substance use: medicinal drug or THC < amphetamine/methamphetamine < alcohol. For most substances, higher ORs were found when studying drivers involved in single vehicle accidents than for those involved in multiple vehicle accidents, but confidence intervals were wider.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376919     DOI: 10.1016/j.aap.2010.12.034

Source DB:  PubMed          Journal:  Accid Anal Prev        ISSN: 0001-4575


  24 in total

1.  Fatal crashes from drivers testing positive for drugs in the U.S., 1993-2010.

Authors:  Fernando A Wilson; Jim P Stimpson; José A Pagán
Journal:  Public Health Rep       Date:  2014 Jul-Aug       Impact factor: 2.792

2.  Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010.

Authors:  Joanne E Brady; Guohua Li
Journal:  Am J Epidemiol       Date:  2014-01-29       Impact factor: 4.897

Review 3.  The epidemiologic principles underlying traffic safety study designs.

Authors:  June H Kim; Stephen J Mooney
Journal:  Int J Epidemiol       Date:  2016-08-14       Impact factor: 7.196

4.  Cannabis effects on driving lateral control with and without alcohol.

Authors:  Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; Russell S Pierce; David A Gorelick; Gary Gaffney; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2015-06-23       Impact factor: 4.492

Review 5.  Cannabis effects on driving skills.

Authors:  Rebecca L Hartman; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-12-07       Impact factor: 8.327

Review 6.  Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.

Authors:  Toni M Rudisill; Motao Zhu; George A Kelley; Courtney Pilkerton; Brandon R Rudisill
Journal:  Accid Anal Prev       Date:  2016-08-29

7.  Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study.

Authors:  Shiu-Dong Chung; Ching-Chun Lin; Li-Hsuan Wang; Herng-Ching Lin; Jiunn-Horng Kang
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

8.  Risk factors for fatal and nonfatal road crashes in iran.

Authors:  Mohammadreza Mehmandar; Hamid Soori; Mosa Amiri; Reza Norouzirad; Mehdi Khabzkhoob
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611

9.  A case-control study estimating accident risk for alcohol, medicines and illegal drugs.

Authors:  Kim Paula Colette Kuypers; Sara-Ann Legrand; Johannes Gerardus Ramaekers; Alain Gaston Verstraete
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

10.  Alcohol, psychoactive substances and non-fatal road traffic accidents--a case-control study.

Authors:  Stig Tore Bogstrand; Hallvard Gjerde; Per Trygve Normann; Ingeborg Rossow; Øivind Ekeberg
Journal:  BMC Public Health       Date:  2012-09-03       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.